Spots Global Cancer Trial Database for Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer
Official Title: Malaysian Tocotrienol Rich Fraction: Immunomodulatory Effect in Women With Breast Cancer
Study ID: NCT03855423
Conditions
Interventions
Study Description
Brief Summary: Phase Ib: Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women with Breast Cancer is aimed to determine the highest, safest and tolerable dose of Tocotrienol-rich Fraction (maximal tolerated dose: MTD) that can be used in women with breast cancer.
Detailed Description: 3+3 step up design method will be used in this study.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University of Malaya Medical Center, Kuala Lumpur, , Malaysia
Contact Details
Name: Nur Aishah Taib, MBBS
Affiliation: University of Malaya
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
